{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:57:39Z","timestamp":1770670659478,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate cancer (PCa) incidence has steadily increased in Sweden, more steeply in the mid-1990s caused by increased opportunistic prostate-specific antigen (PSA) testing. Tallness, normal weight, and non-smoking are associated with more PSA testing, which increases detection of low-risk and localised PCa. We investigated time trends of height, body mass index (BMI), and smoking with PCa risk in 171,889 men in Sweden aged 50\u201364 years at baseline, who were linked to nationwide cancer registers during follow-up. Cox regression determined the association of these factors assessed before 1980, 1980\u20131994, and 1995\u20132004 with PCa risk. During 15 follow-up years, 8,049 men were diagnosed with PCa. The association of height with PCa was weakly positive across all calendar periods. For obesity (BMI\u2009\u226530\u00a0kg\/m<jats:sup>2<\/jats:sup>) vs. normal weight (BMI 18.5\u201324.9\u00a0kg\/m<jats:sup>2<\/jats:sup>) and current vs. never smoking, the associations changed from null before 1980 (HR 1.03, 95% CI 0.86\u20131.23, and 1.11, 95% CI 0.97\u20131.27) to negative in 1995\u20132004 (HR 0.83, 95% CI 0.74\u20130.93, and 0.86, 95% CI 0.79\u20130.93; p<jats:sub>interaction<\/jats:sub> between periods\u2009=\u20090.05 and 0.001). In men with clinical characteristics available, height was positively associated with both aggressive and non-aggressive PCa whilst obesity and smoking showed negative associations only with non-aggressive PCa. These findings likely reflect differences in PSA testing by BMI and smoking habits and contribute important knowledge for etiological studies of PCa.<\/jats:p>","DOI":"10.1038\/s41598-025-06548-y","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T08:24:45Z","timestamp":1750839885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden"],"prefix":"10.1038","volume":"15","author":[{"given":"Innocent B.","family":"Mboya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Scilipoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"H\u00e4ggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Wahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Oskarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Micha\u00eblsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Chabok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik K. E.","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ylva Trolle","family":"Lagerros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Bonn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnea","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"6548_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia, G. et al. Epidemiology and prevention of prostate Cancer. Eur. Urol. Oncol. 4, 877\u2013892 (2021).","journal-title":"Eur. Urol. Oncol."},{"key":"6548_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp, M. B., Soerjomataram, I., Efstathiou, J. A., Bray, F. & Jemal, A. Recent global patterns in prostate cancer incidence and mortality rates. Eur. Urol. 77, 38\u201352 (2020).","journal-title":"Eur. Urol."},{"key":"6548_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/21681805.2022.2094462","volume":"56","author":"O Bratt","year":"2022","unstructured":"Bratt, O. et al. The Swedish National guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease. Scand. J. Urol. 56, 265\u2013273 (2022).","journal-title":"Scand. J. Urol."},{"key":"6548_CR4","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/ijc.30924","volume":"141","author":"R Kvale","year":"2017","unstructured":"Kvale, R. et al. Prostate and breast cancer in four nordic countries: A comparison of incidence and mortality trends across countries and age groups 1975\u20132013. Int. J. Cancer. 141, 2228\u20132242 (2017).","journal-title":"Int. J. Cancer"},{"key":"6548_CR5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jama.2024.4011","volume":"331","author":"RM Martin","year":"2024","unstructured":"Martin, R. M. et al. Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.. JAMA 331, 1460\u20131470 (2024).","journal-title":"JAMA"},{"key":"6548_CR6","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1002\/ijc.33150","volume":"147","author":"SHJ Jochems","year":"2020","unstructured":"Jochems, S. H. J. et al. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category. Int. J. Cancer. 147, 3328\u20133338 (2020).","journal-title":"Int. J. Cancer"},{"key":"6548_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canep.2016.09.010","volume":"45","author":"TJ Littlejohns","year":"2016","unstructured":"Littlejohns, T. J., Travis, R. C., Key, T. J. & Allen, N. E. Lifestyle factors and prostate-specific antigen (PSA) testing in UK biobank: implications for epidemiological research. Cancer Epidemiol. 45, 40\u201346 (2016).","journal-title":"Cancer Epidemiol."},{"key":"6548_CR8","doi-asserted-by":"publisher","first-page":"e1004362","DOI":"10.1371\/journal.pmed.1004362","volume":"21","author":"H Cui","year":"2024","unstructured":"Cui, H. et al. Risk factors for prostate cancer: an umbrella review of prospective observational studies and Mendelian randomization analyses. PLoS Med. 21, e1004362 (2024).","journal-title":"PLoS Med."},{"key":"6548_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10552-012-0108-6","volume":"24","author":"A Rundle","year":"2013","unstructured":"Rundle, A. et al. A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer. Cancer Causes Control. 24, 297\u2013303 (2013).","journal-title":"Cancer Causes Control"},{"key":"6548_CR10","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12889-023-16085-w","volume":"23","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Association of cigarette smoking habits with the risk of prostate cancer: a systematic review and meta-analysis. BMC Public. Health. 23, 1150 (2023).","journal-title":"BMC Public. Health"},{"key":"6548_CR11","doi-asserted-by":"publisher","first-page":"104154","DOI":"10.1016\/j.ebiom.2022.104154","volume":"82","author":"SC Larsson","year":"2022","unstructured":"Larsson, S. C. & Burgess, S. Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies.. EBioMedicine 82, 104154 (2022).","journal-title":"EBioMedicine"},{"key":"6548_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.eururo.2022.03.033","volume":"83","author":"SHJ Jochems","year":"2023","unstructured":"Jochems, S. H. J. et al. Smoking and risk of prostate Cancer and prostate Cancer death: A pooled study. Eur. Urol. 83, 422\u2013431 (2023).","journal-title":"Eur. Urol."},{"key":"6548_CR13","doi-asserted-by":"publisher","first-page":"i582","DOI":"10.1136\/bmj.i582","volume":"352","author":"J Tyrrell","year":"2016","unstructured":"Tyrrell, J. et al. Height, body mass index, and socioeconomic status: Mendelian randomisation study in UK biobank. BMJ 352, i582 (2016).","journal-title":"BMJ"},{"key":"6548_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/ije\/dyl011","volume":"35","author":"PKE Magnusson","year":"2006","unstructured":"Magnusson, P. K. E., Rasmussen, F. & Gyllensten, U. B. Height at age 18 years is a strong predictor of attained education later in life: cohort study of over 950 000 Swedish men. Int. J. Epidemiol. 35, 658\u2013663 (2006).","journal-title":"Int. J. Epidemiol."},{"key":"6548_CR15","doi-asserted-by":"publisher","first-page":"e084836","DOI":"10.1136\/bmjopen-2024-084836","volume":"14","author":"M da Silva","year":"2024","unstructured":"da Silva, M. et al. Cohort profile: the obesity and disease development Sweden (ODDS) study, a pooled cohort. BMJ Open. 14, e084836 (2024).","journal-title":"BMJ Open."},{"key":"6548_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow, L., Westergren, K., Holmberg, L. & Talback, M. The completeness of the Swedish Cancer register: a sample survey for year 1998. Acta Oncol. 48, 27\u201333 (2009).","journal-title":"Acta Oncol."},{"key":"6548_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/ije\/dys068","volume":"42","author":"M Van Hemelrijck","year":"2013","unstructured":"Van Hemelrijck, M. et al. Cohort profile: the National prostate Cancer register of Sweden and prostate Cancer data base Sweden 2.0. Int. J. Epidemiol. 42, 956\u2013967 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"6548_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13629-017-0168-1","volume":"7","author":"P Stattin","year":"2017","unstructured":"Stattin, P., Sandin, F., Hellstr\u00f6m, K., Robinson, D. & Franck Lissbrant, I. The National prostate Cancer register of sweden: basis for quality assessment, quality improvement, and research. Tijdschrift Voor Urologie. 7, 50\u201359 (2017).","journal-title":"Tijdschrift Voor Urologie"},{"key":"6548_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke, H. L. et al. The Swedish cause of death register. Eur. J. Epidemiol. 32, 765\u2013773 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"6548_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson, J. F. et al. Registers of the Swedish total population and their use in medical research. Eur. J. Epidemiol. 31, 125\u2013136 (2016).","journal-title":"Eur. J. Epidemiol."},{"key":"6548_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson, J. F., Svedberg, P., Olen, O., Bruze, G. & Neovius, M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur. J. Epidemiol. 34, 423\u2013437 (2019).","journal-title":"Eur. J. Epidemiol."},{"key":"6548_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/21681805.2017.1411392","volume":"52","author":"J Hugosson","year":"2018","unstructured":"Hugosson, J. et al. Eighteen-year follow-up of the Goteborg randomized Population-based prostate Cancer screening trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality. Scand. J. Urol. 52, 27\u201337 (2018).","journal-title":"Scand. J. Urol."},{"key":"6548_CR23","doi-asserted-by":"publisher","first-page":"dju007","DOI":"10.1093\/jnci\/dju007","volume":"106","author":"P Stattin","year":"2014","unstructured":"Stattin, P. et al. Prostate cancer mortality in areas with high and low prostate cancer incidence. J. Natl. Cancer Inst. 106, dju007 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"6548_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10654-005-4263-x","volume":"20","author":"B J\u00e4rvholm","year":"2005","unstructured":"J\u00e4rvholm, B., Lewold, S., Malchau, H. & Ving\u00e5rd, E. Age, bodyweight, smoking habits and the risk of severe osteoarthritis in the hip and knee in men. Eur. J. Epidemiol. 20, 537\u2013542 (2005).","journal-title":"Eur. J. Epidemiol."},{"key":"6548_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/jnci\/djaa154","volume":"113","author":"LM Hurwitz","year":"2021","unstructured":"Hurwitz, L. M. et al. Recommended definitions of aggressive prostate Cancer for etiologic epidemiologic research. J. Natl. Cancer Inst. 113, 727\u2013734 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"6548_CR26","unstructured":"IARC. NORDCAN, Association of the Nordic Cancer Registries, vol. : International Agency for Research on Cancer, World Health Organization, 2024. (2024)."},{"key":"6548_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman, D. G. & Bland, J. M. Statistics Notes - Interaction revisited: the difference between two estimates. Bmj-Brit Med. J. 326, 219 (2003).","journal-title":"Bmj-Brit Med. J."},{"key":"6548_CR28","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1210\/jc.2006-0388","volume":"91","author":"I Rogers","year":"2006","unstructured":"Rogers, I. et al. Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J. Clin. Endocrinol. Metabolism. 91, 2514\u20132519 (2006).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"6548_CR29","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Continuous Update Project Expert Report, Diet, nutrition, physical activity and prostate cancer, (2018)."},{"key":"6548_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.annonc.2019.09.007","volume":"31","author":"J Genkinger","year":"2020","unstructured":"Genkinger, J. et al. Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in the pooling project of prospective studies of diet and Cancer. Ann. Oncol. 31, 103\u2013114 (2020).","journal-title":"Ann. Oncol."},{"key":"6548_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","volume":"387","author":"NCD Risk Factor Collaboration","year":"2016","unstructured":"NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b7 2 million participants. Lancet (London England). 387, 1377 (2016).","journal-title":"Lancet (London England)"},{"key":"6548_CR32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/jnci\/djm249","volume":"99","author":"R Kv\u00e5le","year":"2007","unstructured":"Kv\u00e5le, R. et al. Interpreting trends in prostate cancer incidence and mortality in the five nordic countries. J. Natl Cancer Inst. 99, 1881\u20131887 (2007).","journal-title":"J. Natl Cancer Inst."},{"key":"6548_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10552-020-01291-3","volume":"31","author":"S Harrison","year":"2020","unstructured":"Harrison, S. et al. Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen. Cancer Causes Control. 31, 431\u2013449 (2020).","journal-title":"Cancer Causes Control"},{"key":"6548_CR34","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10552-015-0654-9","volume":"26","author":"NM Davies","year":"2015","unstructured":"Davies, N. M. et al. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control. 26, 1603\u20131616 (2015).","journal-title":"Cancer Causes Control"},{"key":"6548_CR35","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ije\/dyw129","volume":"45","author":"C Gao","year":"2016","unstructured":"Gao, C. et al. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int. J. Epidemiol. 45, 896\u2013908 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"6548_CR36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.eururo.2014.08.059","volume":"66","author":"F Islami","year":"2014","unstructured":"Islami, F., Moreira, D. M., Boffetta, P. & Freedland, S. J. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur. Urol. 66, 1054\u20131064 (2014).","journal-title":"Eur. Urol."},{"key":"6548_CR37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.addbeh.2012.02.006","volume":"37","author":"JJ Rolison","year":"2012","unstructured":"Rolison, J. J., Hanoch, Y. & Miron-Shatz, T. Smokers: at risk for prostate cancer but unlikely to screen. Addict. Behav. 37, 736\u2013738 (2012).","journal-title":"Addict. Behav."},{"key":"6548_CR38","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.orcp.2019.10.006","volume":"13","author":"J Tuomela","year":"2019","unstructured":"Tuomela, J. et al. Accuracy of self-reported anthropometric measures\u2014Findings from the Finnish twin study. Obes. Res. Clin. Pract. 13, 522\u2013528 (2019).","journal-title":"Obes. Res. Clin. Pract."},{"key":"6548_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/obr.12881","volume":"20","author":"V De Rubeis","year":"2019","unstructured":"De Rubeis, V., Bayat, S., Griffith, L. E., Smith, B. T. & Anderson, L. N. Validity of self-reported recall of anthropometric measures in early life: a systematic review and meta\u2010analysis. Obes. Rev. 20, 1426\u20131440 (2019).","journal-title":"Obes. Rev."},{"key":"6548_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","volume":"63","author":"T Nordstr\u00f6m","year":"2013","unstructured":"Nordstr\u00f6m, T. et al. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm county, sweden, despite no recommendations for PSA screening: results from a population-based study, 2003\u20132011. Eur. Urol. 63, 419\u2013425 (2013).","journal-title":"Eur. Urol."},{"key":"6548_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.breast.2021.05.011","volume":"59","author":"M Lagerlund","year":"2021","unstructured":"Lagerlund, M., Akesson, A. & Zackrisson, S. Population-based mammography screening attendance in Sweden 2017\u20132018: A cross-sectional register study to assess the impact of sociodemographic factors. Breast 59, 16\u201326 (2021).","journal-title":"Breast"},{"key":"6548_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/CEJ.0000000000000025","volume":"24","author":"M Lagerlund","year":"2015","unstructured":"Lagerlund, M., Drake, I., Wirf\u00e4lt, E., Sontrop, J. M. & Zackrisson, S. Health-related lifestyle factors and mammography screening attendance in a Swedish cohort study. Eur. J. Cancer Prev. 24, 44\u201350 (2015).","journal-title":"Eur. J. Cancer Prev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06548-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06548-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06548-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T21:02:25Z","timestamp":1751230945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06548-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6548"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06548-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20290"}}